Healthcare Triangle is trading 5.1% down at $1.48 after announcing plans to acquire a 51% stake in CosmoAesthetics Pty Ltd valued at $23.5 million.
- The deal is funded through a combination of cash, equity, and performance-based consideration, marking a strategic pivot toward MedTech product innovation.
- The stock's decline likely reflects investor reaction to the acquisition structure alongside generally weak risk sentiment in the broader market.